Stock Events

Stock Events

Evoke Pharma 

$11
20
+$0.04+0.36% Tuesday 20:55

Statistics

Day High
11
Day Low
10.98
52W High
11
52W Low
1.94
Volume
47,096
Avg. Volume
96,574
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

Earnings

12MarExpected
Q2 2024
Q3 2024
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q4 2025
-0.94
-0.73
-0.51
-0.3
Expected EPS
-0.3
Actual EPS
N/A

Financials

-52.22%Profit Margin
Unprofitable
2019
2020
2021
2022
2023
2024
10.25MRevenue
-5.35MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow EVOK. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Astrazeneca
AZN
Mkt Cap256.58B
AstraZeneca has a strong portfolio in gastrointestinal drugs, competing in the same market as Evoke Pharma.
Takeda Pharmaceutical
TAK
Mkt Cap42.62B
Takeda Pharmaceutical Company has a significant presence in gastroenterology, making it a direct competitor.
Abbvie
ABBV
Mkt Cap385.18B
AbbVie has a range of products for gastrointestinal diseases, competing with Evoke's offerings.
Johnson & Johnson
JNJ
Mkt Cap455.04B
Johnson & Johnson, through its pharmaceutical division Janssen, offers medications for gastrointestinal health, competing with Evoke.
Sanofi
SNY
Mkt Cap124.45B
Sanofi has a diversified portfolio that includes treatments for gastrointestinal disorders, making it a competitor.
Pfizer
PFE
Mkt Cap140.15B
Pfizer has a broad range of pharmaceutical products, including treatments for gastrointestinal conditions, competing with Evoke.
Novartis
NVS
Mkt Cap237.61B
Novartis offers several medications for gastrointestinal diseases, directly competing with Evoke Pharma's products.
Merck
MRK
Mkt Cap214.76B
Merck has a presence in the gastrointestinal drug market, making it a competitor to Evoke Pharma.
GSK
GSK
Mkt Cap94.51B
GlaxoSmithKline produces medications for a variety of conditions, including gastrointestinal diseases, competing with Evoke.

About

Evoke Pharma, Inc., a specialty pharmaceutical company, primarily focuses on the development and commercialization of drugs for the treatment of gastroenterological disorders and diseases. It is developing Gimoti, a metoclopramide nasal spray that has completed Phase 3 clinical trials to treat symptoms associated with acute and recurrent diabetic gastroparesis in females. The company markets its products to gastroenterologists, internal medicine specialists, primary care physicians, and select health care providers. Evoke Pharma, Inc. was incorporated in 2007 and is headquartered in Solana Beach, California.
Show more...
CEO
Mr. Matthew J. D'Onofrio MBA
Employees
3
Country
US
ISIN
US30049G2030

Listings

0 Comments

Share your thoughts

FAQ

What is Evoke Pharma stock price today?▼
The current price of EVOK is $11 USD — it has increased by +0.36% in the past 24 hours. Watch Evoke Pharma stock price performance more closely on the chart.
What is Evoke Pharma stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Evoke Pharma stocks are traded under the ticker EVOK.
Is Evoke Pharma stock price growing?▼
EVOK stock has risen by +0% compared to the previous week, the month change is a +0% rise, over the last year Evoke Pharma has showed a +324.71% increase.
What is Evoke Pharma revenue for the last year?▼
Evoke Pharma revenue for the last year amounts to 10.25M USD.
What is Evoke Pharma net income for the last year?▼
EVOK net income for the last year is -5.35M USD.
How many employees does Evoke Pharma have?▼
As of April 02, 2026, the company has 3 employees.
In which sector is Evoke Pharma located?▼
Evoke Pharma operates in the Health Care sector.
When did Evoke Pharma complete a stock split?▼
The last stock split for Evoke Pharma was on August 01, 2024 with a ratio of 1:12.
Where is Evoke Pharma headquartered?▼
Evoke Pharma is headquartered in Solana Beach, US.